Revolution Medicines, Inc. is 6.3x more valuable than CG Oncology, Inc. by market capitalization ($30.74 B vs $4.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CGON | RVMD |
|---|---|---|
| Market cap | $4.84 B | $30.74 B |
| US-listed rank | #1405 | #453 |
| Revenue (latest FY) | $4.04M | $0.00 |
| Net income (latest FY) | -$161.00M | -$1.13B |
| Net margin | -3985.1% | - |
| SEC filings | 189 | 782 |
Revolution Medicines, Inc. is 6.3x more valuable than CG Oncology, Inc. by market capitalization ($30.74 B vs $4.84 B).
In their latest fiscal years, CG Oncology, Inc. reported $4.04M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: CG Oncology, Inc. and Revolution Medicines, Inc., or browse the full rankings.